Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

China flag China · Delayed Price · Currency is CNY
19.39
+0.22 (1.15%)
Mar 10, 2026, 2:05 PM CST
17.66%
Market Cap 8.70B
Revenue (ttm) 3.37B
Net Income (ttm) 414.26M
Shares Out 454.07M
EPS (ttm) 0.91
PE Ratio 21.09
Forward PE 17.83
Dividend 0.30 (1.56%)
Ex-Dividend Date May 21, 2025
Volume 3,264,045
Average Volume 4,576,519
Open 18.17
Previous Close 19.17
Day's Range 18.17 - 19.43
52-Week Range 16.39 - 28.90
Beta 0.30
RSI 50.31
Earnings Date Mar 31, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company provides anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poult... [Read more]

Sector Healthcare
Founded 1998
Employees 2,900
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300119
Full Company Profile

Financial Performance

In 2024, SHE:300119's revenue was 3.07 billion, an increase of 13.32% compared to the previous year's 2.71 billion. Earnings were 300.72 million, a decrease of -33.70%.

Financial Statements

News

There is no news available yet.